Article Information
History
- January 11, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Matthew K. Wynia, MD, MPHa,i,j,
- Laurel E. Beaty, MSb,
- Tellen D. Bennett, MD, MSc,f,
- Nichole E. Carlson, PhD, MSb,f,
- Christopher B. Davis, MDd,
- Bethany M. Kwan, PhD, MSPHd,e,f,
- David A. Mayer, BSb,
- Toan C. Ong, PhDc,
- Seth Russell, MSc,
- Jeffrey Steele, RNg,
- Heather R. Stocker, MAe,
- Adane F. Wogu, PhDb,
- Richard D. Zane, MDd,
- Ronald J. Sokol, MDf,h and
- Adit A. Ginde, MD, MPHd,f,*
- aCenter for Bioethics and Humanities, University of Colorado, Anschutz Medical Campus, Aurora, CO
- bDepartment of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO
- cSection of Informatics and Data Science, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO
- dDepartment of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO
- eDepartment of Family Medicine, University of Colorado School of Medicine, Aurora, CO
- fColorado Clinical and Translational Sciences Institute, University of Colorado Anschutz Medical Campus, Aurora, CO
- gResearch Informatics, Children’s Hospital Colorado, Aurora, CO
- hSection of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO
- iDepartment of Medicine, University of Colorado School of Medicine, Aurora, CO
- jDepartment of Health Systems Management and Policy, Colorado School of Public Health, Aurora, CO
- ↵*Corresponding author
Adit A. Ginde, MD, MPH, Department of Emergency Medicine, University of Colorado School of Medicine, 12401 E. 17th Ave, Mail Stop B-215, Aurora, CO 80045, USA, Phone: +1-720-848-6777, Email: adit.ginde{at}cuanschutz.edu
See Supplement for a full list of Contributors.
Posted January 11, 2022.
Real World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients
